UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022982
Receipt number R000026494
Scientific Title Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port
Date of disclosure of the study information 2016/08/01
Last modified on 2016/07/01 22:46:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port

Acronym

Study of ethanol lock therapy & antimicrobial lock therapy

Scientific Title

Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port

Scientific Title:Acronym

Study of ethanol lock therapy & antimicrobial lock therapy

Region

Japan


Condition

Condition

Case of catheter-related bloodstream infection in totally implantable central venous port

Classification by specialty

Infectious disease Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the study is to assess the efficacy and safety of ethanol lock & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the efficacy of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.

Key secondary outcomes

To evaluate the safety of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

70% ethanol lock therapy (7 days)
Antimicribial lock therapy (7-14 days)
Systemic antimicrobial therapy (14-21 days)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent home parenteral nutrition by totally implantable central venous port.
2. fever more than 38.0 degree.
3. catheter-related bloodstream infection is suspected.
4. No severe complication by sepsis. General condition is good.
5. No allergy for antimicrobial drugs or ethanol which will be used in this study.
6. Silicine catheter was implanted

Key exclusion criteria

1.Patients with severe sepsis
2.Patients who underwent lock therapy for bacterial infection within 3 months
3.Patients who underwent lock therapy for fungal infection
4.Patients with pregnancy
5. Patients who doctors regarded as inadequate to participate this study.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiro Watanabe

Organization

Tohoku University Hospital

Division name

Gastrointestinal Surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7205

Email

k-wata@surg1.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuhiro Watanabe

Organization

Tohoku University Hospital

Division name

Gastrointestinal Surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7205

Homepage URL


Email

k-wata@surg1.med.tohoku.ac.jp


Sponsor or person

Institute

Division of Gastrointestinal Surgery, Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

Division of Gastrointestinal Surgery, Tohoku University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 01 Day

Last modified on

2016 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026494


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name